Skip to content

Examination of the effect of single intake of test food on satiety: a crossover trial.

Examination of the effect of single intake of test food on satiety: a crossover trial. - Examination of the effect of single intake of test food on satiety.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000042602
Enrollment
12
Registered
2020-11-30
Start date
2020-11-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Take the test food once Take the placebo food once

Sponsors

IMEQRD Co., Ltd
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Aged 30 to 49 years old at the time of informed consent 2. Japanese female 3. BMI less than 30 4. Those who receive explanations of the clinical trial in advance and obtain written consent by themselves

Exclusion criteria

Exclusion criteria: 1. Those who are currently receiving any types of medicines and/or Chinese medical treatment (except for the drugs taken as needed) 2. Those who have severe liver, kidney, heart, respiratory, endocrine, metabolic diseases, etc. 3. Those who have a history of treatment for heart failure, myocardial infarction, etc. 4. Those who have had gastrointestinal surgery (however, appendicitis is acceptable) 5. Those who are taking health foods (foods or supplements that affect body composition or are intended to maintain or restore health) 6. Those who smoke excessively (21 or more cigarettes / day) 7. Those who drink excessive alcohol (alcohol equivalent 60g or more / day) 8. Those who have or have a history of drug allergies or food allergies 9. Those who work in shifts, such as those who work night shifts 10. Those who are planning to travel abroad, such as traveling abroad, during the test period 11. Those who wish to become pregnant, breastfeeding or during the test period 12. Those who have participated in or are currently participating in other clinical trials within one month before obtaining consent, or those who plan to participate during the trial period 13. Those who are judged by the investigator to be unsuitable for participation in this study

Design outcomes

Primary

MeasureTime frame
Questionnaire (VAS)

Secondary

MeasureTime frame
Leptin, ghrelin, CCK, insulin, glucose (in blood)

Countries

Japan

Contacts

Public ContactHirokuni Kayama

IMEQRD Co., Ltd Planning and Sales Department

clinical-trial@imeqrd.co.jp03-6704-5968

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026